Tirzepatide, the active ingredient in Mounjaro and Zepbound, reduced sleep apnea symptoms for people with obesity. The drug improved sleep apnea symptoms whether or not people used a PAP machine.

The U.S. Supreme Court will hear arguments on Wednesday to decide whether a federal law that guarantees emergency medical care includes abortion. The federal Emergency Medical Treatment and Active ...

Explore the latest in obesity treatment options, including bariatric surgery and GLP-1 medications. Learn how to choose the ...

Stair climbing may significantly lower the risks of heart disease and premature death. This simple daily activity boosts ...

Animal studies suggest that chronic human exposure to methylene chloride may cause cancer, but coffee producers say decaf made with the compound is safe. The FDA permits the sale of decaffeinated ...

For the study, scientists reviewed results from 15 clinical trials that tested fecal microbiota transplants (FMT) — when ...

Taking PPIs like Prisolec and Prevacid was tied to a 70 percent higher risk of migraine or severe headache compared with not ...

New York City city reported 24 cases of leptospirosis in 2023, the highest case count ever, and 6 so far in 2024.

Explore how GLP-1 drugs like Ozempic and Mounjaro are reshaping the conversation around weight loss, with insights from ...

Adopting healthy lifestyle habits like good sleep, exercise, and a balanced diet can significantly lower your risk of ...

Blindness and other severe vision problems increase the risk of suicidal thinking, behavior, and death, according to a large ...

A new study identified the most and least mentally stimulating jobs and determined their link to cognitive decline and ...